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The importance of growth during the fetal and postnatal periods needs to be 
considered for the future, for it concerns the infant’s  developmental, 
cardiovascular, immunological, renal and metabolic outcomes. 
        Methods 
We conducted a longitudinal study in 150 premature neonates on their growth of 
brain, cerebellum, subcutaneous adipose tissue and skeletal muscles. The 
intrauterine growth was considered retarded if body weight (BW) and the ponderal 
index (PI) was below the 10
th
 centile according to the Lubchenco’s neonatal chart. 
The population was hence divided in two groups: one having experienced a normal 
intrauterine growth (NIUG, n = 125, 32.7 ± 2.9 weeks, 1858 ± 574 g) and the other a 
restricted or retarded intrauterine growth (RIUG, n=25, 33.9 ± 3.95 weeks, 1545 ± 
559 g). The considered parameters were the global anthropometry: weight or BW, 
length or BL, head circumference or HC. The cerebral mass (CM) was calculated from 
head circumference according to Dobbing. The growth of brain and cerebellum was 
evaluated by ultrasounds (height, width, volume and surface area) at birth and every 
weeks after birth (measures in NIUG =372; in RIUG = 81). The lipids content of brain 
and cerebellum (LCB expressed in % of CM) was estimated from its volume, mass  
according to Siri’s equation. The growth of skeletal muscles (MM) was calculated by 
the urinary excretion of creatinine and by the mid left arm muscle circumference 
(LAMC). The subcutaneous adipose tissue (TS) was measured by the skin fold method 
at the mid left arm. The metabolic balances (n=264) were performed over 3 days. 
The range of study was 4 to 40 days of life. 
Results 
The intakes per kg BW in calories, proteins, lipids, carbohydrates and fluids were the 
same in both groups. The caloric cost for weight, brain, muscles and length was 
higher in the RIUG sample, but was the same for HC in both groups. The postnatal 
weekly increase was higher in NIUG concerning BW, MM g, LAMC. It was similar in 
both groups for BL, HC and TS. The caloric cost of growth for brain, length, muscles 
was higher in RIUG neonates. The growth of cerebellum was lower in RIUG all time, 
but increased significantly after birth in these infants. The lipids content in % of 
brain was higher in RIUG than NIUG babies in fetal period and after birth. When 
comparing the efficiency of proteins in different milks, the highest for HC was found 
with human milk. 
Conclusions 
The differences between NIUG and RIUG observed could be explained by the 
quantitative and qualitative differences during fetal and postnatal lives in intakes 
(amino acids, carbohydrates, lipids), by the priorities and the cost for growth due to 
different tissues during fetal and postnatal lives, and by the insulin influence among 
these periods of life. 
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The importance of growth during the fetal and postnatal periods has been established for the 
infant’s future since many years. For the children might be concerned in their developmental, 
cardiovascular, immunological, renal and metabolic outcomes [1-35]. That concept has been 
confirmed by animal studies and by clinical follow-up cohorts of babies at risk. From a 
physiological point of view, the starting point can be the restriction of blood flow through the 
placenta leading to a restricted or retarded intrauterine growth (RIUG) or an inappropriate 
postnatal nutrition or perfusion in different organs (restricted or retarded extrauterine growth or 
REIG). Theses consequences are mediated by the restriction of amino acids delivery to the fetus, 
the inappropriate postnatal (hyper or hypo) nutrition, the response of the renine – angiotensin –
aldosterone complex, the reduced activity of the 11-hydroxysteroid dehydrogenase, the reduced 
NO-dependent vasodilatation response, the increased activity of adrenergic system, the 
reduction in nephrons production in case of important prematurity, the acute or repetitive 
inflammation cascade. We conducted a prospective and longitudinal study in premature 
neonates well fed according to the international recommendations for oral or intravenous 
routes. We centered our analysis on their perinatal growth of brain, cerebellum, subcutaneous 
adipose tissue and skeletal muscles beside the classical parameters as the weight, the length, the 
head circumference. These tissues combine the dependency or independency from insulin 
activity on one hand, and also they have an important quantitative and qualitative place on the 
other hand. We wanted to determine the postnatal priorities among these selected tissues. 
Methods 
Study setting and subjects 
This study was approved by the Ethical Committee. The population comprised 150 premature 
babies without malformations, birth asphyxia or respiratory distress syndrome. This cohort 
represents the “fetal life” sample. It was divided in two groups (Table 1): the babies having 
experienced a normal intrauterine growth or NIUG, and those who had a retarded or restricted 
intrauterine growth or RIUG. The RIUG is a difficult parameter to define and we recently 
discussed that point in other works [36-40]. In this study, owing to a protocol in the Belgian 
group of neonatal intensive care units, RIUG was defined as a birth weight or a ponderal index 
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 centile according to Lubchenco’s neonatal charts. 








That population was then prospectively followed during the neonatal stay, representing 
“the postnatal population sample (Table 2). The primary concept of NIUG and RIUG was 
maintained in their individual trajectory throughout the hospital stay. 
We had to discard 23 (18.4 %) from NIUG and in 7 (28 %) from RIUG infants owing the 
difficulties during their metabolic balances.  







The gestational age at birth was determined according to the late menstrual periods and 
by the Finnström clinical method and the different methods of anthropometric 
measurements applied the usual recommendations [36-76]. The measurements 
reflecting the fetal period were done as early as possible and anyway within the first 6 
hours of life. The postnatal measurements and calculations were done every week 
afterwards.  
 NIUG RIUG 
N 125 25 
Birth weight g 1858 ± 574 1454 ± 559 
Gestational age weeks 32.7 ± 2.9 33.9 ± 3.95 
 NIUG RIUG 
N babies 102 18 
N measures 372 81 
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The anthropometric clinical and echo graphic measurements comprised the body weight 
(BW), the body length (BL), the head circumference (HC). At the mid left arm: circumference 
(LAC), triceps skin fold (LATS), and the derived muscle circumference (LAMC cm = LAC cm - 
0.314 LATS mm). The cerebral mass (CM) was calculated from HC according to Dobbing 
formula [13, 14, and 48]: CM g = [(HC
3
)/100] – [1500/HC]. The parameters measured by 
ultrasounds were (Figure 1):  from coronal and lateral cuts at the level of third ventricle the 
height of frontal lobes and the hemispheric area and volume; from posterior coronal and 
lateral cuts the height, width and surface area and volume of cerebellum.  
 
Figure 1 . The intracranial structures are visualized an measured through anterior and posterior 
fontanelles in their different dimensions (coronal, horizontal  and sagittal cuts). 
 
The in vivo tissue lipids’ content (LCT) was estimated from the LATS and from Siri’s formula [14] 
that takes into account the density and volume of tissues: LCB % = [(Volume/CM)*495 – [450]. 
The body skeletal muscles mass or MM was calculated from the creatinine excretion in urines 
[42, 45]. 
The metabolic balances were done during 3 consecutives days concerning the intakes 
(intravenous and or enteral routes) and the losses (in stools and in urines). The basal metabolic 
 - 6 - 
6 
 
rate was calculated from the continuously record of heart frequency according to Chessex and 
collaborators [46, 50]. The dosage of proteins was done by Kjedhal method, the dosage if lipids 
by the method of Sperri, and the dosage of carbohydrates by HPLC chromatography. The 
dosage of insulin and C-peptide was made by radio-immunoassay. The coefficient of efficiency 
of proteins for growth (CEP) is the ratio of what was obtained in growth divided by 100 g of 
proteins intake. This could be done for the HC, the BW, and the BL. 
The caloric cost of growth was calculated for the body, the brain and the skeletal muscles. 
Results 
Concerning the intakes expressed /kg BW/day, the comparison between NIUG and RIUG 
evidenced none differences. The averaged values were: 127.5 ± 22.5 kcal, 3.4 ± 0.8 g of 
proteins, 18.2 ± 3.5 g of carbohydrates, 5.1 ± 1.3 g of lipids, and 161 ± 17.4 of fluids. 
In both groups, we found significant (p < 0.05) correlations coming out the analysis of the  
metabolic balances as authors in previous studies [45-50]. The correlations having a very 
strong force of association (r
2
 > 0.8) were: 
- Between caloric intakes and Δ BW (= 0.23 cal intake – 19, r
2
 = 0.98) 
- Between proteins intakes and Δ BW (= 3.4 P intake + 7.3, r
2
 = 0.81) 
- Between proteins intakes and Δ HC (=0.6 P intake +0.25, r
2
 = 0.84) 
- Between proteins intakes and Δ BL (= 0.34 P intake +0.253, r
2
 = 0.82)) 
- Between blood levels of insulin micro U/ml and of glucose mmol/100 ml (= 3.75 -2.3 
G, r
2
 = 0.81) 
- Between C-peptide in urines Pico mole/kg/d and carbohydrates intake g/kg/d (= 60 
CH intake + 200, r
2
 = 0.98) 
- Between gestational age and BMR kcal/kg/d (= 0.79 GA +18.6, r
2
 = 0.98) 
- Between GA and Pt % BW (= 0.257 GA +1.766, r
2
 = 0.81) 
- Between GA and Lip % BW (= 0.811 GA – 19.5, r
2
 = 0.97). 
- Between the ratio (100 *LAC)/HC and gestational age (= 0.56 GA +6.5, r
2
 = 0.83) 
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We found also other significant correlations but with a weaker force of association (r
2
 < 0.6): 
- Between Pt synthesis and BMR (= 0.173 BMR – 2.56, r
2
 = 0.5) 
- Between Pt accretion and BMR (= 0.011 BMR + 1.559, r
2
 = 0.21) 
- Between LAC and GA (= 0.26 GA -1.685, r
2
 = 0.52) 




- Between MM % BW and LAC (= 44.63 – 2 LAC, r
2
 = 0.4) 
- Between TS and GA (= 0.078 GA +0.47, r
2
 = 0.25) 
About the global and focalized postnatal growth, interesting results could be underlined 
concerning the weekly assessment or Δ of different parameters. We observed differences in 
the Δ BW and MM who were significantly higher in the NIUG babies, and no differences in 
the other parameters of growth. The caloric cost of growth concerning BW, BL, brain and 
muscles was significantly higher in the RIUG babies (Table 3). 
Table 3. The postnatal growth of tissues 
 NIUG RIUG P 
Δ BW g 181± 82 133± 76 < 0.05 
Δ BL cm 1 ± 0.57 1 ± 0.74 > 0.05 
Δ HC cm 0.8± 0.34 0.75± 0.34 > 0.05 
Δ LATS mm 0.6 ± 0.59 0.5 ± 0.48 > 0.05 
Δ LAMC cm 0.31± 0.56 0.26 ± 0.52 > 0.05 
Δ MM g 41.6 ± 10 28 ± 5.6 < 0.001 
Caloric cost /g BW 
Caloric cost / cm BL 
4.8±0.5 
798 ± 40 
5.9±1 
1275 ± 145 
< 0.05 
Caloric cost/ g brain 0.55±0.05 1.3±0.23 < 0.01 
Caloric cost/ g MM 0.8±0.08 1.35±0.24 < 0.01 
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What the growth of brain and cerebellum is concerned, the babies in NIUG group had higher 
values in the indices of growth for cerebellum but not for brain during the fetal period. In the 
postnatal period, NIUG had higher values than RIUG for cerebellum and brain. But within the 
RIUG group, the comparison of their growth of brain and cerebellum evidenced a significant 
improvement of cerebellum growth in the postnatal period (Table 4). 
Table 4. The brain and cerebellum indices of growth 
 NIUG IUG P 
Cerebellum    
Δ width mm /week    
- utero period 1.75± 0.24 0.7 ± 0.12 < 0.01 
- postnatal period 1.75 ± 0.3 1 ± 0.18 < 0.01 
Δ area mm
2
 / week    
- utero period 6.3 ± 0.9 5 ± 0.9 < 0.05 
- postnatal period 110 ± 15 85 ± 11.9 < 0.01 
Brain 
hemispheric growth (mm) 
   
- utero period 0.926 HC – 5 0.98 HC – 5 > 0.05 
 0.675 GA +1.09 0.8 GA -4.2 > 0.05 
- postnatal period 0.864 GA – 5.4 0.8 GA – 4 < 0.05 
 0.925 HC – 4.9 0.92 HC – 4.7 > 0.05 
 
It was also interesting to note that the lipid content of brain and cerebellum was higher in 
the RIUG: both in the fetal life and in the postnatal period (Table 5). Again, the comparison 
of their fetal and postnatal period showed a significant decrease (and more similar to what 
was observed in NIUG group) of LCB in the RIUG. 
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Table 5. The Calculated lipids contents of brain (LCB expressed in % of CM) according to 
measured head circumference (HC expressed in cm). Regression lines with SD and r
2
 
 LCB in % CM 
NIUG 
LCB in % CM 
RIUG 
P 
In utero sample 0.633 HC + 6.57 0.675 HC+ 7 < 0.01 
 (sd =6.57, r2 0.98) (sd = 3.8 r2 0.98)  
 (n=125) (n=25)  
Postnatal sample 0.5 HC + 5.4 0.54 HC+ 5.6 < 0.01 
 ((sd = 2.6, r2 0.98) ( sd =3 r2 0.98)  
 (n=372) (n=81)  
 
In the babies, some were completely fed by mother’s milk (HM), other by adapted 
formulas for prematurely (PTF) or term newborns when approaching 37 weeks (TF). For 
head circumference or HC, the CEP was higher for HM: 3.9 ± 0.5 versus 3.3 ± 1 for PTF 
and 3.4 ± for TF (p < 0.05). 
What the synthesis of MM is concerned, the NIUG for a similar fetal gestational age had a 
greater content of MM then RIUG babies. In the postnatal period, NIUG made more muscles 
than RIUG babies, either in enteral or parenteral feeding. But proportionally to BW, the 
increments were similar. Within the NIUG group, the synthesis of MM was higher in the 
postnatal period and during the enteral feeding. In the RIUG, the synthesis remained similar 
when fetal and postnatal periods were compared (Table 6). 
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Table 6. The muscles mass (MM g) according to measured body weight in g (BW) or 
gestational age (GA in weeks) and according to the mode of feeding. 
 NIUG RIUG p 
« fetal sample » MM g MMg  
 
0.18 BW – 55 (r
2
0.25) 0.29 BW -79.7 (r
2
=0.25) < 0.01 
 44.51 GA -1050 (r2=0.37) 30.46 GA - 708 (r2 0.36) < 0.01 
Postnatal sample    
- enteral feeding 
   
MM g 0.26 BW – 41.45 (r
2
=0.6) 0.28 BW – 80 (r
2
 =0.34) < 0.01 
MM g/week 30.5 ± 4 25 ± 6 < 0.01 
MM % BW 26± 3 21 ± 3 < 0.01 
- parenteral feeding    
MM g 0.21 BW – 12.4 (r
2
= 0.54) 0.27 BW -50.3 (r
2
 = 0.56) < 0.01 
MM g/week 34.4 ± 6 27 ± 5 < 0.01 
MM % BW 20.4 ± 4 22 ± 5 > 0.05 
 
Discussion 
The importance of growth during the fetal and postnatal periods has to be considered for the 
future for the points might be concerned in babies’ developmental, cardiovascular, 
immunological, renal and metabolic outcomes. Very important studies have been done during 
the period going from 1980 to 2000 [1-37, 48, 50-78]. This can be explained by the facts that, at 
that time, many questions emerged about the qualitative and quantitative optimality of 
nutrition owing to the neonatal period and the outcome of babies who were born more and 
more premature. We can also recognize the tremendous energy devoted by some groups to 
theses questions, evidenced by the numerous publications. The follow-up studies, but also the 
epidemiology on adults’ situations pointed the antenatal and neonatal situations as the 
probable source of explanation for longer outcome in the developmental, cardiovascular, 
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immunological, renal and metabolic findings [1,3-5,7,9-13,18,24,28,30-35, 79, 80 ]. Beside these 
facts and also thanks to the development of new non aggressive techniques, this translational 
approach (which goes from humans to animals investigations and their feedback) stimulates 
research to refine the therapeutically approach of newborn babies at risk of difficult outcomes. 
This study brings more arguments about the importance of the foetal period and the 
consequent neonatal period. We recognize that the concept of intrauterine growth retardation 
is a major and difficult point. We can also underline that the observed postnatal retarded 
growth in neonates, particularly in very premature babies not having experienced a RIUG, is 
another difficulty of understanding: does that reveal after birth a mechanism began in utero? If 
we consider our observations about cerebellum and brain, we can say that: i. the growth of 
cerebellum is lower in the RIUG in both considered periods; ii. The growth of cerebellum and 
brain in RIUG is better after birth; iii. The growth of brain is slightly lower in RIUG in the 
postnatal period; iv. The higher LCB observed in RIUG in both periods but mainly in foetal life as 
that decrease in the postnatal period, can be explained by the de novo synthesis of lipids from 
carbohydrates. Indeed, when blood flow is reduced, the delivery of oxygen and amino acids is 
more pronounced then the delivery of glucose. We don’t know actually the part of that in what 
is observed in the outcome of babies at risk [80]. If, in the postnatal period, we consider 
moreover the accretion of weight, length, head circumference, muscles, we can conclude, from 
the observed results in NIUG and RIUG, that priority is given to the brain and cerebellum, these 
tissues being more independent than the muscles of insulin action on glycoregulation. These 
facts explain the different caloric cost for growth observed. 
It was also interesting to note that, although the quantity of proteins offered to the babies was 
similar, the proteins of human milk were more efficient to promote the growth of brain as 
reflected by the head circumference. This might be due not solely to the quality of human milk, 
but also to other factors present in human milk. 
Conclusions 
The differences between NIUG and RIUG observed could be explained by the quantitative 
and qualitative differences during fetal and postnatal lives in intakes: blood flow, delivery of 
oxygen, amino acids, carbohydrates, fatty acids. The priority for growth during fetal life 
remains the central nervous in the postnatal life. The cost for growth of different tissues 
reflects that priority. The observed postnatal retarded growth in very premature NIUG might 
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reveal a mechanism present before birth. Human milk, more than solely the quality of 
proteins, is the most efficient nutriment for brain growth. 
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